Table 5.
OC (n = 172) | OP (n = 33) | L (n = 72) | |
---|---|---|---|
HPV+ | 7.0% | 66.7% | 1.4% |
TP53 | 75.6% | 27.3% | 88.9% |
FAT1 | 26.2% | 12.1% | 19.4% |
CDKN2A | 25.6% | 6.1% | 23.6% |
PIK3CA | 17.4% | 30.3% | 25.0% |
NOTCH1 | 21.5% | 6.1% | 18.1% |
OC (n = 172) | OP (n = 33) | L (n = 72) | |
---|---|---|---|
HPV+ | 7.0% | 66.7% | 1.4% |
TP53 | 75.6% | 27.3% | 88.9% |
FAT1 | 26.2% | 12.1% | 19.4% |
CDKN2A | 25.6% | 6.1% | 23.6% |
PIK3CA | 17.4% | 30.3% | 25.0% |
NOTCH1 | 21.5% | 6.1% | 18.1% |